Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome
Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
The catastrophic antiphospholipid syndrome (CAPS) is characterized by thrombosis in more than three organs or systems developing over a short period of time. Despite conventional treatment with a combination of anticoagulation plus corticosteroids plus plasma exchange, and/or intravenous immunoglobulin, mortality remains high and some patients suff...
Alternative Titles
Full title
Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4314298
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4314298
Other Identifiers
ISSN
1759-720X
E-ISSN
1759-7218
DOI
10.1177/1759720X14554793
